Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
CENTRAL EUROPE: Austria has reportedly resumed Dublin transfers to Italy ― Sharp increase in withdrawal of protection for Syrian refugees in Germany ― Evidence of growing anti-Ukrainian sentiment in Poland ― Court ruling paves way for return of some Af…
European Council on Refugees and Exiles (ECRE)
CENTRAL EUROPE: Austria has reportedly resumed Dublin transfers to Italy ― Sharp increase in withdrawal of protection for Syrian refugees in Germany ― Evidence of growing anti-Ukrainian sentiment in Poland ― Court ruling paves way for return of...
Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium
GlobeNewswire, Inc.
-- Chiesi’s abstract presentations highlight clinical insights and patient-reported outcomes in Fabry disease and alpha-mannosidosis -- -- Rooted in patient voice and scientific rigor, this research reflects Chiesi’s long-standing role in...
First Chinese PD-1 Inhibitor Hetronifly® (serplulimab) Recommended by NICE for NHS Lung Cancer Care
EIN Presswire
UK's NICE recommends China's serplulimab (trade name in Europe: Hetronifly) for routine use within the National Health Service (NHS) in England and Wales SHANGHAI, CHINA, August 30, 2026 /EINPresswire.com/ -- A pioneering immune checkpoint...
New Publication Demonstrates Disease-Modifying Potential of TELOBLOCK in Models of Idiopathic Pulmonary Fibrosis
EIN Presswire
VIENNA, AUSTRIA, August 20, 2026 /EINPresswire.com/ -- TAG Therapeutics a biotechnology company developing precision medicines for diseases driven by telomere dysfunction, today announces the publication of compelling preclinical data supporting...
George Medicines announces GMRx2 presentations at the European Society of Cardiology Congress 2026
GlobeNewswire, Inc.
London, UK, Boston, MA, 20 August 2026 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, today announced that data on GMRx2, its single pill low-dose combination...
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
GlobeNewswire, Inc.
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company”), a biotechnology company...
AskBio Presents Baseline Characteristics from Phase 2 Heart Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at European Society of Cardiology Congress
GlobeNewswire, Inc.
Durham, N.C., Aug. 29, 2026 (GLOBE NEWSWIRE) -- Phase 2 GenePHIT trial successfully randomized and completed enrollment of one of the largest gene therapy trials conducted in heart failure to date, with more than 170 participants randomized across...
Nutrition May Help Support Nerve Health Alongside Diabetes Management, Specialists Say
EIN Presswire
Diabetic Nerve Clinic encourages patients to view healthy eating as part of a comprehensive approach to protecting nerve function.
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”) and Austrianova, its joint venture partner in Insulinova, today announced that Insulinova has entered into a Research and Option Agreement...
Nebraska's Forest Health Report for July 2026
Nebraska Forest Service
Eastern Nebraska had some relief from the drought in June but it was a short respite.
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
GlobeNewswire, Inc.
DUBLIN and BRIDGEWATER, N.J., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today highlighted a new post hoc analysis from the landmark...
PwC and Zyter Collaborate to Help Healthcare Organizations Transform Total Cost of Care and Improve Measurable Outcomes
GlobeNewswire, Inc.
Vienna, Virginia, Aug. 06, 2026 (GLOBE NEWSWIRE) -- PwC and Zyter today announced a collaboration designed to help healthcare payers and providers transform total cost of care programs, improve health outcomes, and reduce avoidable cost of care....
Virginia Family Chiropractic & PM Manages Arthritis Without Medication at Falls Church Clinic
EIN Presswire
CBP-certified chiropractors combine joint mobilization, laser therapy, and therapeutic exercise for arthritis patients in Falls Church.
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
GlobeNewswire, Inc.
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing.
NurExone Launches Bioprocess Optimization Initiative to Support Commercial and Clinical Readiness
GlobeNewswire, Inc.
TORONTO and HAIFA, Israel, July 30, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX, OTCQB: NRXBF, FSE: J90) (“NurExone” or the “Company”), a biotechnology company developing exosome-based regenerative therapies, today announced a...
Elix and University of Vienna Enter Joint Research Agreement for AI Drug Discovery
EIN Presswire
TOKYO, JAPAN, July 29, 2026 /EINPresswire.com/ -- Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) and University of Vienna, Austria (represented by the Dean of the Faculty of Life Sciences, Prof. Mag. Dr. Karl-Heinz...
Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™
GlobeNewswire, Inc.
Seasoned finance executive brings more than 20 years of leadership experience across global commercial organizations, including the pharmaceutical and medical technology industries Deep expertise spans commercial operations, capital markets,...
Military medical heroes of World War I
DVIDS - Georgia
“This year, the Military Health System is celebrating 250 years of America by recognizing military medicine’s enduring history of innovation and impact to the warfighter.
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
GlobeNewswire, Inc.
Video webcast now available here ISELIN, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg, bevacizumab...
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
GlobeNewswire, Inc.
STAFFORD, Texas, July 20, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Sign up for:
Austria Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.